Products for Research Use Only
RegisterLogin

HDAC-IN-38

CAT: 0804-HY-146351Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-146351Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HDAC-IN-38 (compound 13) is a potent HDAC inhibitor. HDAC-IN-38 shows similar micro-molar inhibitory activity toward HDAC1, 2, 3, 5, 6, and 8. HDAC-IN-38 increases cerebral blood flow (CBF), attenuates cognitive impairment, and improves hippocampal atrophy. HDAC-IN-38 also increases the level of histone acetylation (H3K14 or H4K5) [1].
CAS Number
2408123-36-2
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/hdac-in-38.html
Solubility
10 mM in DMSO
Smiles
O=C(NO)/C=C/C1=CC=C(C=C1)CNCCCN2C3=C(CCC4=C2C=C(C=C4)Cl)C=CC=C3
Molecular Formula
C27H28ClN3O2
Molecular Weight
461.98
References & Citations
[1]Kaur N, et al. Protective effects of 10,11-dihydro-5H-dibenzo[b, f]azepine hydroxamates on vascular cognitive impairment. Eur J Med Chem. 2020 Feb 1;187:111915.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC2; HDAC3; HDAC5; HDAC6; HDAC8

Related Products

CatalogName
HY-163503HDAC6-IN-38
HY-161688HDAC-IN-73
HY-161984HDAC-IN-76
HY-149370HDAC-IN-60
HY-142965HDAC-IN-28
HY-147892HDAC-IN-42
HY-162487HDAC-IN-72
HY-147966HDAC-IN-43
HY-18362HDAC-IN-5
HY-150597HDAC-IN-46

Alternative Products

CatalogName
GTR19185649-01HDAC-IN-38
T211349-01HDAC-IN-91
T210046-01HDAC-IN-75
T205411-01HDAC-IN-85
T203306-01HDAC-IN-82
T201210-01HDAC-IN-81
T200090-01HDAC-IN-76
T62514-01HDAC-IN-46
T62072-01HDAC-IN-47
T72012-01HDAC-IN-6

Popular Products